VISION

Inspiring transformational change in the

field of oncology diagnostics

MISSION

To develop and deliver accurate, rapid, minimally

invasive oncology diagnostic products utilising our

patented MCM5 antibodies


Arquer Diagnostics is focused on the development and commercialisation of highly accurate minichromosome maintenance (MCM) protein based non-invasive tests for cancer diagnosis and monitoring.
Arquer aim to meet demand expressed by patients, clinicians and payers for cost-effective healthcare technologies that not only enhance patient care but help to reduce overall healthcare costs by improving patient outcomes.

Latest News

@ArquerDx

- 21 hours ago

It goes without saying that #cancer survival is far more likely if the disease is detected early. A new implant dev… https://t.co/AjzkAVnHmP
@ArquerDx

- 2 days ago

Throughout the treatment and diagnosis of #bladdercancer, you will be faced with difficult decisions to make every… https://t.co/jsWtjgKlX0
@ArquerDx

- 3 days ago

We are just one week away from the Grand Final of the #nebizawards in Sedgefield. Less than 24 hours after the Medi… https://t.co/wMpfMp1w6G